Vasta Platform
VSTA
$3.50
Share price
0.29%
Change (1 day)
9.38%
Change (1 year)
Categories
Vasta Platform (VSTA) - Cash on Hand
Cash on Hand as of March 2024 : $61.83 M
According to Vasta Platform's latest financial reports the company has $61.83 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Vasta Platform - Cash on Hand chart (from 2019 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $80.65 M | -5.67% |
| 2021-12-31 | $85.49 M | -44.68% |
| 2020-12-31 | $0.15 B | 1333.78% |
| 2019-12-31 | $10.77 M | -59.15% |
| 2018-12-31 | $26.38 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Verastem Oncology
VSTM | $0.11 B | 78.08% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | $56.13 M | -9.22% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $78.5 M | 26.94% | 🇺🇸 USA |